• Home
  • Applications
  • Divisions
    • Overview
    • Human Therapeutics
    • Protein Production
    • Industrial Products
    • Agricultural Biotech
    • Animal Sciences
  • Technology
  • Company
    • Overview
    • Management Team
    • Board of Directors
    • Newsroom
    • Careers
    • IIBR
  • Contact


  • Executive Management Team

    • Randal J. Kirk, Chairman and Chief Executive Officer
    • Thomas D. Reed, Ph.D., Founder & Chief Science Officer
    • Krish S. Krishnan, Chief Operating Officer

  • Division Presidents

      • Thomas R. Kasser, Ph.D., President of Animal Sciences and Agricultural Biotechnology Divisions and Senior Vice President
      • Jayson M. Rieger, Ph.D., M.B.A., President of Human Therapeutics Division and Senior Vice President
      • Saiid Zarrabian, President of Protein Production Division and Senior Vice President


  • Corporate Executives

    • Don Lehr, Chief Legal Officer
    • Rick Sterling, Chief Financial Officer
    • Darryl Webster, Senior Vice President, Intellectual Property
© 2013 Intrexon Corporation. All Rights Reserved.
  • Home
  • Careers
  • Privacy Policy
  • Contact Us
Latest News:
Intrexon Organizes Around New Synthetic Biology Markets
Soligenix and Intrexon Pursue Melioidosis Therapy Through Worldwide Exclusive Collaboration
Intrexon Corporation Raises $150 Million for Synthetic Biology Initiatives
Search
© 2013 Intrexon Corporation - Synthetic Biology through Better DNA